Valanbio Therapeutics, Inc. — Form D/A
Valanbio Therapeutics, Inc. of RALEIGH, NC, a company, filed a Form D amendment with the SEC on 2020-01-14. The offering totals $600K, of which $421K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-01-14
- Form: D/A
- Accession: 0001771623-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $421K
- Remaining: $179K
- Minimum investment: $7K
- Investors: 5
- Date of first sale: 2018-08-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-348130
Issuer
- Name: Valanbio Therapeutics, Inc.
- CIK: 0001771623
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1120 LONGSTONE WAY, RALEIGH, NC, 27614
- Phone: 919-360-7010
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Clayton Duncan | Director | Oklahoma City, OK |
| Sam Hopkins | Director | Raleigh, NC |
| Moise A Khayrallah | Director | Raleigh, NC |
| Eric J Toone | Director | Raleigh, NC |
| Pei J Zhou | Director | Raleigh, NC |
| Clayton Duncan | Executive Officer | Oklahoma City, OK |
| Moise A Khayrallah | Executive Officer | Raleigh, NC |
| Pei J Zhou | Executive Officer | Raleigh, NC |
Other filings by this issuer (1)
More